Preferentially expressed antigen in melanoma as a novel diagnostic marker differentiating thymic squamous cell carcinoma from thymoma

Thymic squamous cell carcinoma (TSQCC), accounting for 70–80% of thymic carcinoma cases, is distinct from thymoma. However, differential diagnosis for type B3 thymoma is sometimes challenging, even with established markers for TSQCC, including KIT and CD5, which are expressed in ~ 80% of TSQCCs and ...

Descripción completa

Detalles Bibliográficos
Autores principales: Taniguchi, Yohei, Ishida, Mitsuaki, Saito, Tomohito, Ryota, Hironori, Utsumi, Takahiro, Maru, Natsumi, Matsui, Hiroshi, Hino, Haruaki, Tsuta, Koji, Murakawa, Tomohiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378236/
https://www.ncbi.nlm.nih.gov/pubmed/32704057
http://dx.doi.org/10.1038/s41598-020-69260-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378236/
https://www.ncbi.nlm.nih.gov/pubmed/32704057
http://dx.doi.org/10.1038/s41598-020-69260-z

Ejemplares similares